Valuation: NOF Corporation

Market Cap 620B 3.89B 3.36B 3.15B 2.87B 5.4B 372B 5.48B 36.96B 14.49B 186B 14.62B 14.3B P/E 2027 *
15.2x
P/E 2028 * 13.2x
Enterprise Value 557B 3.5B 3.02B 2.83B 2.58B 4.85B 334B 4.92B 33.21B 13.01B 168B 13.13B 12.85B EV / Sales 2027 *
1.82x
EV / Sales 2028 * 1.66x
Free-Float
86.05%
Yield 2027 *
2.45%
Yield 2028 * 2.61%
1 day-5.75%
6 months-5.75%
Current year-5.75%
Current year 17.86
Extreme 17.86
17.86
1 year 17.86
Extreme 17.86
18.95
3 years 14.52
Extreme 14.52
18.96
5 years 13.3
Extreme 13.298333
18.96
10 years 10.7
Extreme 10.7
18.96
Manager TitleAgeSince
Chief Executive Officer 61 31/05/2023
Director of Finance/CFO - 25/06/2026
Chief Tech/Sci/R&D Officer 63 25/06/2026
Director TitleAgeSince
Chairman 70 31/05/2023
Director/Board Member 68 25/06/2020
Director/Board Member 68 31/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
-5.75%-.--% - - 3.89B
-0.86%-2.69%+1.82%+25.61% 123B
-3.37%+8.38%+366.82%+203.33% 49.93B
-1.16%-2.71%-14.37%-42.64% 39.65B
+0.12%-6.26%+16.10%-21.51% 33.96B
+0.17%-4.06%+47.65%+67.25% 24.74B
+1.52%+3.32%+21.26%-33.23% 20.91B
-1.16%-2.30%+352.27%+662.78% 20.24B
+0.52%+7.05%+34.35%+362.07% 18.93B
+2.25%-10.98%+57.15%+230.60% 18.42B
Average -0.77%+0.51%+98.12%+161.59% 38.86B
Weighted average by Cap. -0.78%-0.37%+82.84%+103.97%

Financials

2027 *2028 *
Net sales 306B 1.92B 1.66B 1.56B 1.42B 2.67B 184B 2.7B 18.26B 7.15B 92.11B 7.22B 7.06B 326B 2.05B 1.77B 1.66B 1.51B 2.84B 196B 2.88B 19.43B 7.61B 98.03B 7.68B 7.52B
Net income 41.14B 258M 223M 209M 190M 358M 24.69B 363M 2.45B 961M 12.37B 969M 948M 46.57B 292M 252M 237M 216M 405M 27.94B 411M 2.77B 1.09B 14B 1.1B 1.07B
Net Debt -63B -395M -341M -320M -292M -548M -37.8B -556M -3.75B -1.47B -18.94B -1.48B -1.45B -78.15B -490M -423M -397M -362M -680M -46.89B -690M -4.66B -1.82B -23.49B -1.84B -1.8B
Logo NOF Corporation
NOF Corp is a Japan-based company mainly engaged in businesses related to functional chemicals, pharmaceuticals, medical care, health, and chemicals, and is also engaged in transportation and real estate businesses. It operates through three segments. The Functional Chemicals segment manufactures and sells fatty acids, fatty acid derivatives, surfactants, ethylene oxide and propylene oxide derivatives, petrochemicals, functional polymers, electronic materials, and special rust prevention treatment agents. The Pharmaceuticals, Medical Care, and Health segment manufactures and sells edible processed oils and fats, functional food ingredients, health-related products, biocompatible materials, drug delivery system (DDS) pharmaceutical ingredients. The Chemicals segment manufactures and sells industrial explosives, space-related products, defense-related products, and functional products. The Company is also engaged in transportation, real estate sales, and management businesses.
Employees
4,155
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2,760.50JPY
Average target price
3,800.00JPY
Spread / Average Target
+37.66%

Quarterly revenue - Rate of surprise